{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:58:23Z","timestamp":1790909903938,"version":"4.1.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T00:00:00Z","timestamp":1786752000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA251599"],"award-info":[{"award-number":["R01CA251599"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GM067945"],"award-info":[{"award-number":["GM067945"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01CA236749"],"award-info":[{"award-number":["P01CA236749"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA238039"],"award-info":[{"award-number":["R01CA238039"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01CA163222"],"award-info":[{"award-number":["P01CA163222"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000884","name":"Cancer Research Institute","doi-asserted-by":"publisher","award":["CRI4489"],"award-info":[{"award-number":["CRI4489"]}],"id":[{"id":"10.13039\/100000884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001724","name":"Kosciuszko Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001724","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003212","name":"Sara Elizabeth O'Brien Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003212","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R35CA305086"],"award-info":[{"award-number":["R35CA305086"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P01CA250959"],"award-info":[{"award-number":["P01CA250959"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R00CA271370"],"award-info":[{"award-number":["R00CA271370"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R00CA263194"],"award-info":[{"award-number":["R00CA263194"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008746","name":"National Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008746","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Cell"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.molcel.2026.08.007","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T14:41:33Z","timestamp":1788360093000},"page":"3933-3951.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cyclin E-CDK2 regulates cancer cell transcriptional program and response to immunotherapy through BRD4"],"prefix":"10.1016","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8084-0867","authenticated-orcid":false,"given":"Chen","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabin","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Michowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1929-5254","authenticated-orcid":false,"given":"Aleksandra","family":"Kolodziejczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda L.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof W.","family":"Kotowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Martinez-Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joao","family":"Paulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jindan","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane A.","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finn","family":"Groezinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinaga","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anushree C.","family":"Gulvady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael I.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Foidart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samanta","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan M.","family":"Suski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Fassl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven P.","family":"Gygi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kornelia","family":"Polyak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai W.","family":"Wucherpfennig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Sicinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molcel.2026.08.007_bib1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.semcdb.2020.03.009","article-title":"Mammalian cell cycle cyclins","volume":"107","author":"Mart\u00ednez-Alonso","year":"2020","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.molcel.2026.08.007_bib2","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.tcb.2021.05.001","article-title":"Cyclin E in normal physiology and disease states","volume":"31","author":"Chu","year":"2021","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.molcel.2026.08.007_bib3","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1038\/sj.onc.1208613","article-title":"Cyclin E in normal and neoplastic cell cycles","volume":"24","author":"Hwang","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.molcel.2026.08.007_bib4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nrc.2016.138","article-title":"Cell cycle proteins as promising targets in cancer therapy","volume":"17","author":"Otto","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.molcel.2026.08.007_bib5","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.cub.2003.09.024","article-title":"Cdk2 knockout mice are viable","volume":"13","author":"Berthet","year":"2003","journal-title":"Curr. Biol."},{"key":"10.1016\/j.molcel.2026.08.007_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng1232","article-title":"Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice","volume":"35","author":"Ortega","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molcel.2026.08.007_bib7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1535-6108(03)00053-9","article-title":"Proliferation of cancer cells despite CDK2 inhibition","volume":"3","author":"Tetsu","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molcel.2026.08.007_bib8","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1158\/2159-8290.CD-23-0954","article-title":"INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors","volume":"14","author":"Dietrich","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.molcel.2026.08.007_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-56674-4","article-title":"Discrete vulnerability to pharmacological CDK2 inhibition is governed by heterogeneity of the cancer cell cycle","volume":"16","author":"Kumarasamy","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molcel.2026.08.007_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.adv0415","article-title":"p16 expression confers sensitivity to CDK2 inhibitors in cyclin E1-driven ovarian cancers","volume":"18","author":"Sine","year":"2025","journal-title":"Sci. Signal."},{"key":"10.1016\/j.molcel.2026.08.007_bib11","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1158\/0008-5472.CAN-24-2360","article-title":"Profiling the Activity of the Potent and Highly Selective CDK2 Inhibitor BLU-222 Reveals Determinants of Response in CCNE1-Aberrant Ovarian and Endometrial Tumors","volume":"85","author":"House","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.molcel.2026.08.007_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116140","article-title":"Targeting CDK2 for cancer therapy","volume":"44","author":"Knudsen","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.molcel.2026.08.007_bib13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.36401\/JIPO-24-22","article-title":"Cyclin Dependent Kinase 2 (CDK2) Inhibitors in Oncology Clinical Trials: A Review","volume":"8","author":"House","year":"2025","journal-title":"J. Immunother. Precis Oncol."},{"key":"10.1016\/j.molcel.2026.08.007_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104324","article-title":"Cyclin-dependent kinase 2 (CDK2) inhibitors and others novel CDK inhibitors (CDKi) in breast cancer: clinical trials, current impact, and future directions","volume":"196","author":"Gerosa","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.molcel.2026.08.007_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2024.08.386","article-title":"VZO-021-1001: A first-in-human open-label, multicenter phase I\/II dose-escalation and expansion study evaluating AVZO-021 in adult patients with advanced solid tumors","volume":"35","author":"Dowlati","year":"2024","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.molcel.2026.08.007_bib16","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2025.43.16_suppl.5514","article-title":"Safety and preliminary efficacy from a phase 1 study of INCB123667, a selective CDK2 inhibitor, in patients with advanced platinum-resistant and refractory ovarian cancer (OC)","volume":"43","author":"Damian","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.molcel.2026.08.007_bib17","doi-asserted-by":"crossref","first-page":"S598","DOI":"10.1016\/j.annonc.2025.08.1543","article-title":"974P First-in-human phase I dose finding study of INCB123667, a selective CDK2 inhibitor, in patients with advanced solid tumors","volume":"36","author":"Lorusso","year":"2025","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.molcel.2026.08.007_bib18","doi-asserted-by":"crossref","first-page":"P4","DOI":"10.1158\/1557-3265.SABCS24-P4-10-16","article-title":"Abstract P4-10-16: INX-315, an oral, potent and selective CDK2 inhibitor in patients with CDK4\/6 inhibitor resistant ER+\/HER2- breast cancer or CCNE1 amplified solid tumors: Phase 1 monotherapy dose escalation","volume":"31","author":"Tan","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.molcel.2026.08.007_bib19","article-title":"First-in-human phase 1\/2a study of a potent and novel CDK2-selective inhibitor PF-07104091 in patients (pts) with advanced solid tumors, enriched for CDK4\/6 inhibitor resistant HR+\/HER2- breast cancer","volume":"41","author":"Yap","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.molcel.2026.08.007_bib20","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1073\/pnas.1711477115","article-title":"Kinase-independent function of E-type cyclins in liver cancer","volume":"115","author":"Geng","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.molcel.2026.08.007_bib21","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1080\/15384101.2020.1804720","article-title":"The requirement for cyclin E in c-Myc overexpressing breast cancers","volume":"19","author":"Zhou","year":"2020","journal-title":"Cell Cycle (Georget. Tex.)"},{"key":"10.1016\/j.molcel.2026.08.007_bib22","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.molcel.2020.03.010","article-title":"Cdk1 Controls Global Epigenetic Landscape in Embryonic Stem Cells","volume":"78","author":"Michowski","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molcel.2026.08.007_bib23","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/35030148","article-title":"A chemical switch for inhibitor-sensitive alleles of any protein kinase","volume":"407","author":"Bishop","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2026.08.007_bib24","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2024-5709","article-title":"PF-07104091, a first-in-class CDK2-selective inhibitor for the treatment of HR+\/HER2- breast cancer and CCNE1high ovarian cancer","volume":"84","author":"Shen","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.molcel.2026.08.007_bib25","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-020-1934-6","article-title":"Lisa: inferring transcriptional regulators through integrative modeling of public chromatin accessibility and ChIP-seq data","volume":"21","author":"Qin","year":"2020","journal-title":"Genome Biol."},{"key":"10.1016\/j.molcel.2026.08.007_bib26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/9780470559277.ch090201","article-title":"Chemical genetic approach for kinase-substrate mapping by covalent capture of thiophosphopeptides and analysis by mass spectrometry","volume":"2","author":"Hertz","year":"2010","journal-title":"Curr. Protoc. Chem. Biol."},{"key":"10.1016\/j.molcel.2026.08.007_bib27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrd4286","article-title":"Targeting bromodomains: epigenetic readers of lysine acetylation","volume":"13","author":"Filippakopoulos","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.molcel.2026.08.007_bib28","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1016\/j.cell.2025.07.004","article-title":"Cancer immunology data engine reveals secreted AOAH as a potential immunotherapy","volume":"188","author":"Gong","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.molcel.2026.08.007_bib30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene Expression Omnibus: NCBI gene expression and hybridization array data repository","volume":"30","author":"Edgar","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molcel.2026.08.007_bib31","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/j.immuni.2023.08.014","article-title":"Dendritic cells as shepherds of T cell immunity in cancer","volume":"56","author":"Pittet","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.molcel.2026.08.007_bib32","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1084\/jem.20101158","article-title":"Type I interferon is selectively required by dendritic cells for immune rejection of tumors","volume":"208","author":"Diamond","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molcel.2026.08.007_bib33","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.4049\/jimmunol.1101313","article-title":"Type I IFN drives a distinctive dendritic cell maturation phenotype that allows continued class II MHC synthesis and antigen processing","volume":"188","author":"Simmons","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.molcel.2026.08.007_bib34","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1084\/jem.20101159","article-title":"Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells","volume":"208","author":"Fuertes","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molcel.2026.08.007_bib35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/toxsci\/kfad049","article-title":"Use of the dTAG system in vivo to degrade CDK2 and CDK5 in adult mice and explore potential safety liabilities","volume":"194","author":"Yenerall","year":"2023","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.molcel.2026.08.007_bib36","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1128\/MCB.00952-08","article-title":"Cdk2 and Cdk4 activities are dispensable for tumorigenesis caused by the loss of p53","volume":"29","author":"Padmakumar","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molcel.2026.08.007_bib37","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/ncb1284","article-title":"Cdc2-cyclin E complexes regulate the G1\/S phase transition","volume":"7","author":"Aleem","year":"2005","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.molcel.2026.08.007_bib38","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1016\/j.cell.2023.05.013","article-title":"Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity","volume":"186","author":"Arora","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.molcel.2026.08.007_bib39","doi-asserted-by":"crossref","DOI":"10.1186\/gb4184","article-title":"Cyclin-dependent kinases","volume":"15","author":"Malumbres","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.molcel.2026.08.007_bib40","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1158\/1535-7163.MCT-23-0677","article-title":"Targeting Transcriptional Cyclin-Dependent Kinases in Cancer","volume":"24","author":"Kolodziejczyk","year":"2025","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.molcel.2026.08.007_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz9899","article-title":"A novel landscape of nuclear human CDK2 substrates revealed by in situ phosphorylation","volume":"6","author":"Chi","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.molcel.2026.08.007_bib42","doi-asserted-by":"crossref","first-page":"5556","DOI":"10.1158\/0008-5472.CAN-13-0013","article-title":"Hbo1 is a cyclin E\/CDK2 substrate that enriches breast cancer stem-like cells","volume":"73","author":"Duong","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.molcel.2026.08.007_bib43","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1074\/jbc.M114.602532","article-title":"Cyclin E-CDK2 protein phosphorylates plant homeodomain finger protein 8 (PHF8) and regulates its function in the cell cycle","volume":"290","author":"Sun","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molcel.2026.08.007_bib44","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/ncb2116","article-title":"Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2","volume":"12","author":"Chen","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.molcel.2026.08.007_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-13105-5","article-title":"CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer","volume":"10","author":"Nie","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molcel.2026.08.007_bib46","first-page":"1009","article-title":"Phosphorylation of EZH2 at T416 by CDK2 contributes to the malignancy of triple negative breast cancers","volume":"7","author":"Yang","year":"2015","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.molcel.2026.08.007_bib47","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","article-title":"Selective inhibition of tumor oncogenes by disruption of super-enhancers","volume":"153","author":"Lov\u00e9n","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.molcel.2026.08.007_bib48","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","article-title":"BET bromodomain inhibition as a therapeutic strategy to target c-Myc","volume":"146","author":"Delmore","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.molcel.2026.08.007_bib49","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1038\/s41388-018-0135-1","article-title":"Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma","volume":"37","author":"Bolin","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.molcel.2026.08.007_bib50","doi-asserted-by":"crossref","first-page":"12968","DOI":"10.1073\/pnas.0901418106","article-title":"Inactivation of CDK2 is synthetically lethal to MYCN over-expressing cancer cells","volume":"106","author":"Molenaar","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.molcel.2026.08.007_bib51","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/15384101.2020.1855740","article-title":"Pharmacological inactivation of CDK2 inhibits MYC\/BCL-XL-driven leukemia in vivo through induction of cellular senescence","volume":"20","author":"Bazzar","year":"2021","journal-title":"Cell Cycle (Georget. Tex.)"},{"key":"10.1016\/j.molcel.2026.08.007_bib52","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41573-020-0077-5","article-title":"Targeting the epigenetic regulation of antitumour immunity","volume":"19","author":"Hogg","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.molcel.2026.08.007_bib53","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/j.celrep.2017.02.011","article-title":"BET-Bromodomain Inhibitors Engage the Host Immune System and Regulate Expression of the Immune Checkpoint Ligand PD-L1","volume":"18","author":"Hogg","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.molcel.2026.08.007_bib54","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1172\/JCI86437","article-title":"BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models","volume":"126","author":"Kagoya","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.molcel.2026.08.007_bib55","article-title":"The BET family in immunity and disease","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.molcel.2026.08.007_bib56","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1158\/2326-6066.CIR-21-0806","article-title":"CDK2 Inhibition Enhances Antitumor Immunity by Increasing IFN Response to Endogenous Retroviruses","volume":"10","author":"Chen","year":"2022","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.molcel.2026.08.007_bib57","article-title":"Inhibition of tumor-intrinsic NAT10 enhances antitumor immunity by triggering type I interferon response via MYC\/CDK2\/DNMT1 pathway","volume":"16","author":"Liu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molcel.2026.08.007_bib58","article-title":"CDK2 inhibitor BLU-222 synergizes with CDK4\/6 inhibitors in drug resistant breast cancers through p21\/p27 induction","volume":"17","author":"Luo","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molcel.2026.08.007_bib59","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1016\/j.celrep.2016.08.032","article-title":"BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression","volume":"16","author":"Zhu","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.molcel.2026.08.007_bib60","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1046\/j.0022-202x.2001.01495.x","article-title":"Decreased growth inhibitory responses of squamous carcinoma cells to interferon-gamma involve failure to recruit cki proteins into cdk2 complexes","volume":"117","author":"Harvat","year":"2001","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.molcel.2026.08.007_bib61","first-page":"613","article-title":"Type I interferon prolongs cell cycle progression via p21WAF1\/CIP1 induction in human colon cancer cells","volume":"31","author":"Katayama","year":"2007","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.molcel.2026.08.007_bib62","doi-asserted-by":"crossref","first-page":"26589","DOI":"10.1074\/jbc.M301491200","article-title":"The tumor suppressor interferon regulatory factor 1 interferes with SP1 activation to repress the human CDK2 promoter","volume":"278","author":"Xie","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molcel.2026.08.007_bib63","article-title":"CDK2 inhibition sensitizes anthracycline-induced immunogenic cell death and enhances the efficacy of anti-PD-1 therapy","volume":"16","author":"Chen","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molcel.2026.08.007_bib96","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.3390\/cancers14143361","article-title":"CDK inhibition primes for anti-PD-L1 treatment in triple-negative breast cancer models","volume":"14","author":"Cheung","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.molcel.2026.08.007_bib64","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/35095076","article-title":"Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line","volume":"413","author":"Strohmaier","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2026.08.007_bib65","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/35095068","article-title":"Archipelago regulates Cyclin E levels in Drosophila and is mutated in human cancer cell lines","volume":"413","author":"Moberg","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2026.08.007_bib66","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1126\/science.1065203","article-title":"Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase","volume":"294","author":"Koepp","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.molcel.2026.08.007_bib67","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1158\/2159-8290.CD-19-1416","article-title":"Inactivation of Fbxw7 Impairs dsRNA Sensing and Confers Resistance to PD-1 Blockade","volume":"10","author":"Gstalder","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.molcel.2026.08.007_bib68","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc1495","article-title":"CDK4 and CDK6 kinases: From basic science to cancer therapy","volume":"375","author":"Fassl","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.molcel.2026.08.007_bib69","article-title":"Bromodomain-Containing Protein BRD4 Is Hyperphosphorylated in Mitosis","volume":"12","author":"Wang","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.molcel.2026.08.007_bib70","first-page":"E5352","article-title":"Uncovering BRD4 hyperphosphorylation associated with cellular transformation in NUT midline carcinoma","volume":"114","author":"Wang","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.molcel.2026.08.007_bib71","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1016\/j.molcel.2024.09.030","article-title":"Phosphorylation by JNK switches BRD4 functions","volume":"84","author":"Devaiah","year":"2024","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molcel.2026.08.007_bib72","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.4197","article-title":"Salmon provides fast and bias-aware quantification of transcript expression","volume":"14","author":"Patro","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.molcel.2026.08.007_bib73","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.molcel.2026.08.007_bib74","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14049","article-title":"Massively parallel digital transcriptional profiling of single cells","volume":"8","author":"Zheng","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molcel.2026.08.007_bib75","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","article-title":"Dictionary learning for integrative, multimodal and scalable single-cell analysis","volume":"42","author":"Hao","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.molcel.2026.08.007_bib76","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.molcel.2026.08.007_bib77","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2008-9-9-r137","article-title":"Model-based analysis of ChIP-Seq (MACS)","volume":"9","author":"Zhang","year":"2008","journal-title":"Genome Biol."},{"key":"10.1016\/j.molcel.2026.08.007_bib78","doi-asserted-by":"crossref","first-page":"W187","DOI":"10.1093\/nar\/gku365","article-title":"deepTools: a flexible platform for exploring deep-sequencing data","volume":"42","author":"Ram\u00edrez","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molcel.2026.08.007_bib79","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/bib\/bbs017","article-title":"Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration","volume":"14","author":"Thorvaldsd\u00f3ttir","year":"2013","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.molcel.2026.08.007_bib80","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.molcel.2026.08.007_bib81","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1093\/nar\/gkg584","article-title":"Scansite 2.0: Proteome-wide prediction of cell signaling interactions using short sequence motifs","volume":"31","author":"Obenauer","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molcel.2026.08.007_bib82","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nmeth.3047","article-title":"Improved vectors and genome-wide libraries for CRISPR screening","volume":"11","author":"Sanjana","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.molcel.2026.08.007_bib83","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb2210","article-title":"Increased lysosomal biomass is responsible for the resistance of triple-negative breast cancers to CDK4\/6 inhibition","volume":"6","author":"Fassl","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.molcel.2026.08.007_bib84","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.molcel.2011.11.005","article-title":"Chemical genetic screen for AMPKalpha2 substrates uncovers a network of proteins involved in mitosis","volume":"44","author":"Banko","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molcel.2026.08.007_bib85","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.molcel.2016.06.035","article-title":"ZMYND8 Reads the Dual Histone Mark H3K4me1-H3K14ac to Antagonize the Expression of Metastasis-Linked Genes","volume":"63","author":"Li","year":"2016","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molcel.2026.08.007_bib86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106748","article-title":"Discovery and validation of new potential biomarkers for early detection of colon cancer","volume":"9","author":"Sol\u00e9","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.molcel.2026.08.007_bib87","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1053\/j.gastro.2009.11.005","article-title":"Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer","volume":"138","author":"Smith","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molcel.2026.08.007_bib88","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/nm733","article-title":"Gene-expression profiles predict survival of patients with lung adenocarcinoma","volume":"8","author":"Beer","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.molcel.2026.08.007_bib89","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1158\/1078-0432.CCR-12-2321","article-title":"A 12-gene set predicts survival benefits from adjuvant chemotherapy in non-small cell lung cancer patients","volume":"19","author":"Tang","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.molcel.2026.08.007_bib90","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.jtho.2020.07.005","article-title":"Multi-Institutional Prospective Validation of Prognostic mRNA Signatures in Early Stage Squamous Lung Cancer (Alliance)","volume":"15","author":"Bueno","year":"2020","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.molcel.2026.08.007_bib91","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal gene signatures in large-B-cell lymphomas","volume":"359","author":"Lenz","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molcel.2026.08.007_bib92","doi-asserted-by":"crossref","first-page":"12297","DOI":"10.18632\/oncotarget.3655","article-title":"Molecular stratification of metastatic melanoma using gene expression profiling: Prediction of survival outcome and benefit from molecular targeted therapy","volume":"6","author":"Cirenajwis","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.molcel.2026.08.007_bib93","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1158\/0008-5472.CAN-10-0021","article-title":"In silico estimates of tissue components in surgical samples based on expression profiling data","volume":"70","author":"Wang","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.molcel.2026.08.007_bib94","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/annonc\/mdx637","article-title":"Validation of a Metastatic Assay using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapy","volume":"29","author":"Jain","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.molcel.2026.08.007_bib95","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41523-022-00502-1","article-title":"Predictors of success in establishing orthotopic patient-derived xenograft models of triple negative breast cancer","volume":"9","author":"Echeverria","year":"2023","journal-title":"npj Breast Cancer"}],"container-title":["Molecular Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109727652600554X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109727652600554X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:14:08Z","timestamp":1790867648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109727652600554X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":95,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S109727652600554X"],"URL":"https:\/\/doi.org\/10.1016\/j.molcel.2026.08.007","relation":{},"ISSN":["1097-2765"],"issn-type":[{"value":"1097-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclin E-CDK2 regulates cancer cell transcriptional program and response to immunotherapy through BRD4","name":"articletitle","label":"Article Title"},{"value":"Molecular Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molcel.2026.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}